Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced renal cell carcinoma (RCC) (HCRN GU16-260).
暂无分享,去创建一个
P. Catalano | Catherine J. Wu | S. Signoretti | M. Atkins | E. Plimack | J. Sosman | C. Drake | M. Hurwitz | B. Rini | D. Peace | D. McDermott | M. Bilen | H. Hammers | N. Haas | R. Alter | O. Jegede